Trademark: 88809129
Status Date
Wednesday, December 29, 2021
Filing Date
Tuesday, February 25, 2020
Published for Opposition
Tuesday, March 30, 2021
Abandoned Date
Wednesday, December 29, 2021
1 a protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells
5 pharmaceutical preparations for the treatment of white blood cell diseases in the form of protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells
Dec 29, 2021
Abandonment Notice E-Mailed - Inter Partes Decision
Dec 29, 2021
Abandonment - After Inter Partes Decision
Dec 29, 2021
Opposition Terminated No. 999999
Dec 29, 2021
Opposition Sustained No. 999999
Sep 24, 2021
Opposition Instituted No. 999999
Apr 23, 2021
Extension Of Time To Oppose Received
Mar 30, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 30, 2021
Published For Opposition
Mar 10, 2021
Notification Of Notice Of Publication E-Mailed
Feb 25, 2021
Approved For Pub - Principal Register
Feb 24, 2021
Teas/Email Correspondence Entered
Feb 24, 2021
Correspondence Received In Law Office
Feb 23, 2021
Assigned To Lie
Nov 20, 2020
Teas Response To Office Action Received
May 20, 2020
Notification Of Non-Final Action E-Mailed
May 20, 2020
Non-Final Action E-Mailed
May 20, 2020
Non-Final Action Written
May 14, 2020
Assigned To Examiner
Feb 28, 2020
New Application Office Supplied Data Entered In Tram
Feb 28, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
